Cargando…
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
H-1 parvovirus (H-1PV) is a promising anticancer therapy. However, in-depth understanding of its life cycle, including the host cell factors needed for infectivity and oncolysis, is lacking. This understanding may guide the rational design of combination strategies, aid development of more effective...
Autores principales: | Kulkarni, Amit, Ferreira, Tiago, Bretscher, Clemens, Grewenig, Annabel, El-Andaloussi, Nazim, Bonifati, Serena, Marttila, Tiina, Palissot, Valérie, Hossain, Jubayer A., Azuaje, Francisco, Miletic, Hrvoje, Ystaas, Lars A. R., Golebiewska, Anna, Niclou, Simone P., Roeth, Ralf, Niesler, Beate, Weiss, Amélie, Brino, Laurent, Marchini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219832/ https://www.ncbi.nlm.nih.gov/pubmed/34158478 http://dx.doi.org/10.1038/s41467-021-24034-7 |
Ejemplares similares
-
Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells
por: Ferreira, Tiago, et al.
Publicado: (2022) -
H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future
por: Bretscher, Clemens, et al.
Publicado: (2019) -
Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
por: Li, Junwei, et al.
Publicado: (2013) -
Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects
por: Hossain, Jubayer A, et al.
Publicado: (2020) -
Oncolytic parvoviruses: from basic virology to clinical applications
por: Marchini, Antonio, et al.
Publicado: (2015)